The excursion occurred lasted for a total of 31 minutes lowest temperature reached was Negative 0.1C with no reported adverse event; states that she is contacting Medical Information again to inform that 17 patients have received these vaccines after the temperature excursion has occurred, with no reported adverse event; Initial information received on 17-May-2022 regarding an unsolicited valid non-serious case received from a other health professional.  This case involves an unknown age and unknown gender patient who experienced the excursion occurred lasted for a total of 31 minutes lowest temperature reached was negative 0.1c with no reported adverse event and states that she is contacting medical information again to inform that 17 patients have received these vaccines after the temperature excursion has occurred, with no reported adverse event while receiving vaccines Meningococcal a-c-y-w135 (d conj) vaccine [menactra], ipv (vero) [ipol], diphtheria-2/tetanus/5 ac pertussis vaccine [adacel] and hib (prp/t) vaccine [act-hib].  The patient's past medical history, medical treatment(s), vaccination(s) and family history were not provided.   On an unknown date, the patient received a  dose of suspect HIB (PRP/T) Vaccine suspension for injection unknown dosage form strength, dose, frequency,  expiration date and lot number via unknown route in unknown administration site for immunization. On an unknown date, the patient received a  dose of suspect Diphtheria-2/tetanus/5 ac pertussis vaccine suspension for injection unknown dosage form strength, dose, frequency,  expiration date and  lot number via unknown route in unknown administration site for immunization. On an unknown date, the patient received a  dose of suspect IPV (VERO) suspension for injection unknown dosage form strength, dose, frequency,  expiration date and lot number via unknown route in unknown administration site for immunization. On an unknown date, the patient received a  dose of suspect meningococcal a-c-y-w135 (d conj) vaccine suspension for injection unknown dosage form strength, dose, frequency, expiration date and lot number via unknown route in unknown administration site for immunization.  On 22-APR-2022 the patient developed a non-serious the excursion occurred lasted for a total of 31 minutes lowest temperature reached was negative 0.1c with no reported adverse event (product storage error) (unknown latency) following the administration of hib (prp/t) vaccine, (unknown latency) following the administration of diphtheria-2/tetanus/5 ac pertussis vaccine, (unknown latency) following the administration of ipv (vero) and (unknown latency) following the administration of meningococcal a-c-y-w135 (d conj) vaccine. On 22-APR-2022 the patient developed a non-serious states that she is contacting medical information again to inform that 17 patients have received these vaccines after the temperature excursion has occurred, with no reported adverse event (product administration error) (unknown latency) following the administration of hib (prp/t) vaccine, diphtheria-2/tetanus/5 ac pertussis vaccine, IPV (VERO) and Meningococcal a-c-y-w135 (d conj) vaccine.  Action taken with haemophilus type b (hib) vaccine (act-hib), diphtheria, tetanus and acellular pertussis vaccine (adacel), poliomyelitis vaccine (inactivated) (ipol) and meningococcal vaccine (menactra) was not applicable.  It was not reported if the patient received a corrective treatment for the events (The excursion occurred lasted for a total of 31 minutes lowest temperature reached was Negative 0.1C with no reported adverse event, states that she is contacting Medical Information again to inform that 17 patients have received these vaccines after the temperature excursion has occurred, with no reported adverse event).  At time of reporting, the outcome was Unknown for the event the excursion occurred lasted for a total of 31 minutes lowest temperature reached was negative 0.1c with no reported adverse event and was Unknown for the event states that she is contacting medical information again to inform that 17 patients have received these vaccines after the temperature excursion has occurred, with no reported adverse event.  This suspected adverse reaction report is submitted and classified as a medication error solely and exclusively to ensure the marketing authorization holder's compliance with the requirements set out in the Directive 2001/83/EC and Module VI of the Good Pharmacovigilance Practices. The classification as a medical error is in no way intended, nor should it be interpreted or construed as an allegation or claim made by the marketing authorization holder that any third party has contributed to or is to be held liable for the occurrence of this medication error.